WallStreetZenWallStreetZen

NASDAQ: ECOR
Electrocore Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ECOR

Based on 1 analyst offering 12 month price targets for Electrocore Inc

Min Forecast
$18.00+193.64%
Avg Forecast
$18.00+193.64%
Max Forecast
$18.00+193.64%

Should I buy or sell ECOR stock?

Based on 1 analyst offering ratings for Electrocore Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ECOR's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ECOR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ECOR stock forecasts and price targets.

ECOR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-26

1 of 1

Forecast return on equity

Is ECOR forecast to generate an efficient return?

Forecast return on assets

Is ECOR forecast to generate an efficient return on assets?

Company
N/A
Industry
15.08%

ECOR earnings per share forecast

What is ECOR's earnings per share in the next 2 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$1.44
Avg 2 year Forecast
-$0.63

ECOR revenue forecast

What is ECOR's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$42.9M+34.03%
Avg 2 year Forecast
$56.0M+74.8%
Avg 3 year Forecast
$78.0M+143.36%
ECOR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ECOR revenue growth forecast

How is ECOR forecast to perform vs Medical Devices companies and vs the US market?

Company
33.32%
Industry
9.05%
Market
13.37%
ECOR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ECOR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ECOR vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ECOR$6.13$18.00+193.64%Buy
ELUT$1.11N/AN/A
ICCM$0.64$2.50+292.46%Buy
MDAI$1.72$3.00+74.42%Strong Buy
ARAY$0.38$2.00+427.70%Strong Buy
View Top Medical Device Stocks

Electrocore Stock Forecast FAQ

Is Electrocore Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ECOR) stock is to Buy ECOR stock.

Out of 1 analyst, 0 (0%) are recommending ECOR as a Strong Buy, 1 (100%) are recommending ECOR as a Buy, 0 (0%) are recommending ECOR as a Hold, 0 (0%) are recommending ECOR as a Sell, and 0 (0%) are recommending ECOR as a Strong Sell.

If you're new to stock investing, here's how to buy Electrocore stock.

What is ECOR's earnings growth forecast for 2026-2027?

(NASDAQ: ECOR) Electrocore's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.17%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.92%.

Electrocore's earnings in 2026 is -$13,966,000.On average, 6 Wall Street analysts forecast ECOR's earnings for 2026 to be -$11,637,898, with the lowest ECOR earnings forecast at -$13,071,113, and the highest ECOR earnings forecast at -$9,845,774.

In 2027, ECOR is forecast to generate -$5,114,467 in earnings, with the lowest earnings forecast at -$6,812,823 and the highest earnings forecast at -$1,706,439.

What is ECOR's revenue growth forecast for 2026-2028?

(NASDAQ: ECOR) Electrocore's forecast annual revenue growth rate of 33.32% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.05%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.37%.

Electrocore's revenue in 2026 is $32,032,000.On average, 6 Wall Street analysts forecast ECOR's revenue for 2026 to be $347,035,228, with the lowest ECOR revenue forecast at $316,778,471, and the highest ECOR revenue forecast at $373,904,975. On average, 6 Wall Street analysts forecast ECOR's revenue for 2027 to be $452,614,580, with the lowest ECOR revenue forecast at $395,973,089, and the highest ECOR revenue forecast at $525,447,437.

In 2028, ECOR is forecast to generate $630,145,680 in revenue, with the lowest revenue forecast at $537,758,696 and the highest revenue forecast at $721,174,627.

What is ECOR's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ECOR) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 15.08%.

What is ECOR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ECOR price target, the average ECOR price target is $18.00, with the highest ECOR stock price forecast at $18.00 and the lowest ECOR stock price forecast at $18.00.

The Wall Street analyst predicted that Electrocore's share price could reach $18.00 by Jan 26, 2027. The average Electrocore stock price prediction forecasts a potential upside of 193.64% from the current ECOR share price of $6.13.

What is ECOR's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: ECOR) Electrocore's current Earnings Per Share (EPS) is -$1.65. On average, analysts forecast that ECOR's EPS will be -$1.44 for 2026, with the lowest EPS forecast at -$1.62, and the highest EPS forecast at -$1.22. In 2027, ECOR's EPS is forecast to hit -$0.63 (min: -$0.84, max: -$0.21).

What is ECOR's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ECOR) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.